Fourth Annual PMO Live Virtual Conference

Part 1: Welcome and Introduction

Jorge Cortes, MD

Part 2: A Primer on the Clinical Application of Molecular Biomarkers: What to Order and How to Use the Results

Michael W. Kattan, PhD; Katherine A. Hoadley, PhD; Towia A. Libermann, PhD; Mark Sausen, PhD

Part 3: Exploring Molecular Pathways in Cancer

Alex A. Adjei, MD, PhD, FACP

Part 4: What’s New in Cancer Biomarker Research?

Jerald Radich, MD; Philip C. Mack, PhD

Part 5: Innovative Molecular Pathways and Biomarkers in Treating Solid Tumors

Sanjiv S. Agarwala, MD; Mark A. Socinski, MD; Joyce O’Shaughnessy, MD; William M. Grady, MD

Part 6: Targeting Genetic Drivers in Premalignancy

Scott M. Lippman, MD

Part 7: Case Studies—Innovative Molecular Pathways and Biomarkers in Treating Hematologic Malignancies

Jorge Cortes, MD; A. Keith Stewart, MB ChB; Michael J. Keating, MB, BS; Joseph M. Connors, MD

Part 8: An Industry Perspective on the Use of Biomarkers in Cancer: How Are They Really Used?

Roman Yelensky, PhD

Part 9: The Impact of Molecular Biomarkers on Clinical Trials

Funda Meric-Bernstam, MD

Part 10: Regulatory and Economic Aspects of Precision Medicine

Andrew Stainthorpe, PhD; Michael Kolodziej, MD, FACP